# BIONICS Israel Trial

> **NCT02834806** · NA · COMPLETED · sponsor: **Medinol Ltd.** · enrollment: 58 (actual)

## Conditions studied

- Stenosis

## Interventions

- **DEVICE:** BioNIR Ridaforolimus Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT02834806
- **Lead sponsor:** Medinol Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-01-16
- **Final completion:** 2017-12-16
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02834806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02834806, "BIONICS Israel Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02834806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*